| Hans-Günter Meyer-Thompson | Naloxon
USA. FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder
USA. FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder
Consider prescribing naloxone to those at increased risk of opioid overdose.
07-23-2020 FDA Drug Safety Communication.